There is a complex relationship between bacteria and cancer (reported previously). Now, scientists at Israel’s Weizmann Institute have discovered that bacteria inside cancer cells can provoke an immune reaction against the tumor, which chemotherapy can further exploit.
Israel’s BrainsWay (reported previously) is now using its transcranial magnetic stimulation (TMS) technology to treat patients suffering with depression due to Covid. It is focusing on those struggling with recovery, who have lost loved ones, in financial difficulties etc.
Ben Gurion University scientists studying naturally occurring ionizing radiation in the US, discovered that, contrary to expectations, higher levels of radiation lead to lower levels of many solid cancers. Levels of other cancers were not influenced by background radiation levels.
Israel’s “R” factor – the average number of people that one person infects with the SARS-Cov-2 virus – has fallen to just over 0.5 and less than 1% of tests are returning positive. Israel has no “red” (high infection rate) cities for the first time since the start of the pandemic.
Israel’s Revitalvision has developed vision training software to improve eyesight in adult amblyopia, eye diseases and vision impairments. The FDA-approved therapy uses Gabor patches with a patented stimulation technique to stimulate the visual cortex and create new neural connections.
When United Hatzalah volunteer medic Alan Malka saved a 30-year-old man who suffered a heart attack in Petah Tikva, he recognized that he saved the same man two months previously. Resuscitation was much quicker this time, and he now should get treatment to prevent a further incident.
Doctors from Israel’s Sheba Medical Centre are flying out to Dubai to treat an initial 350 diabetes patients in the UAE army, police, and firefighting services. Sheba is also sending physicians to train medical staff at Medcare Women & Children Hospital in Dubai.
Some 1.8 million people are bitten by snakes each year – about 94,000 fatally. An international research team including Tel Aviv University’s Eyal Goldstein have designed a model to determine (and so avoid) the probability of a snakebite at specific places, months, and times of day.
The IPUD (Implantable Peritoneal Ultrafiltration Device) from Israel’s Paragate Medical (reported previously) removes excess fluid from patients coping with chronic heart and kidney failure at home. Paragate is a portfolio company of Nazareth’s NGT3. Human trials start soon.
Israel’s Oramed (reported previously) has launched Oravax – a joint venture with India’s Premas Biotech to develop a Covid-19 vaccine. The vaccine is administered orally (not injected) and targets 3 virus proteins, so should counter any mutations. Human trials expected soon.